- Profits at Dr Reddy's fell 93% due to rising research costs and flagging sales.
- Sales in Dr Reddy's generics business fell 8.6% to 966m rupees.
- The firm said its profits were 40m rupees for the three months to December.
- Dr Reddy's has built its reputation on producing generic versions of pharmaceutical products.
- Dr Reddy's Indian competitors are gathering strength.
